| # | Drug | Count |
|---|---|---|
| 0 | CARBOPLATIN | 24 |
| 1 | ETOPOSIDE | 23 |
| 2 | DOXORUBICIN | 16 |
| 3 | TOPOTECAN | 15 |
| 4 | CYCLOPHOSPHAMIDE | 10 |
| 5 | CYCLOPHOSPHAMIDE FOR INJECTION | 10 |
| 6 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 10 |
| 7 | DOXORUBICIN HYDROCHLORIDE | 10 |
| 8 | CISPLATIN | 9 |
| 9 | TOPOTECAN HYDROCHLORIDE | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TOPOTECAN HYDROCHLORIDE | 8 | 0.0033 |
| 1 | CERITINIB | 6 | 0.0025 |
| 2 | TOPOTECAN | 15 | 0.0024 |
| 3 | BRIGATINIB | 6 | 0.0016 |
| 4 | DINUTUXIMAB | 1 | 0.0012 |
| 5 | ALECTINIB HYDROCHLORIDE | 5 | 0.0007 |
| 6 | SARGRAMOSTIM | 1 | 0.0006 |
| 7 | CRIZOTINIB | 6 | 0.0005 |
| 8 | FAMCICLOVIR | 1 | 0.0004 |
| 9 | ETOPOSIDE | 23 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 1 | 0.0009 |
| 1 | Topoisomerase Inhibitor [EPC] | 24 | 0.0003 |
| 2 | CD33-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 3 | Gadolinium-based Contrast Agent [EPC] | 1 | 0.0002 |
| 4 | Platinum-based Drug [EPC] | 32 | 0.0001 |
| 5 | Programmed Death Ligand-1 Blocker [EPC] | 2 | 0.0001 |
| 6 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 7 | Alkylating Drug [EPC] | 11 | 0.0000 |
| 8 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Aluminum Complex [EPC] | 1 | 0.0000 |